NLRP12 Suppresses Colon Inflammation and Tumorigenesis through the Negative Regulation of Noncanonical NF-κB Signaling
Open Access
- 25 May 2012
- journal article
- research article
- Published by Elsevier BV in Immunity
- Vol. 36 (5), 742-754
- https://doi.org/10.1016/j.immuni.2012.03.012
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Control of Intestinal Homeostasis, Colitis, and Colitis-Associated Colorectal Cancer by the Inflammatory CaspasesImmunity, 2010
- IKKα and IKKβ Each Function to Regulate NF-κB Activation in the TNF-Induced/Canonical PathwayPLOS ONE, 2010
- How the Noninflammasome NLRs Function in the Innate Immune SystemScience, 2010
- Constitutive noncanonical NFκB signaling in pancreatic cancer cellsCancer Biology & Therapy, 2009
- ATP Binding by Monarch-1/NLRP12 Is Critical for Its Inhibitory FunctionMolecular and Cellular Biology, 2008
- Mutations in NALP12 cause hereditary periodic fever syndromesProceedings of the National Academy of Sciences of the United States of America, 2008
- NLRX1 is a regulator of mitochondrial antiviral immunityNature, 2008
- Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitisJCI Insight, 2008
- Flat Colorectal Cancers Are Genetically Determined and Progress to Invasion without Going through a Polypoid StageCancer Research, 2007
- NOD2 Transgenic Mice Exhibit Enhanced MDP-Mediated Down-Regulation of TLR2 Responses and Resistance to Colitis InductionGastroenterology, 2007